Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

St Vincent's Hospital Commences First Global APAS In Situ Automation Evaluation

publication date: Oct 23, 2017
 | 
author/source: LBT Innovations

Australian developed advanced pathology instrument reading and interpreting plates for faster diagnosis of infectious diseases - Center of excellence laboratory to test automation efficiency in a busy real-life setting

LBT InnovationsAustralian medical technology company LBT Innovations Limited and joint venture company Clever Culture Systems AG (CCS) have installed their APAS® Independence instrument at St Vincent’s Hospital in Melbourne to commence its first global in situ evaluation.

APAS® is a breakthrough artificial intelligence technology for the automated imaging, image analysis, interpretation and reporting of growth on microbiology plates after incubation. The APAS® Independence, which is about the size of a large photocopier, improves the clinical efficiency of microbiology laboratories and enables faster diagnosis and reporting of infectious diseases. The US FDA-cleared instrument is based on LBT’s Australian- developed intelligent imaging and machine learning software.

Placement of the instrument at a center of excellence such as St Vincent’s Hospital will enable the evaluation of the instrument’s performance and provide valuable feedback in a diagnostic pathology laboratory.  Training pathology scientists at the hospital on the APAS® Independence instrument began this week.

Microbiologists and scientists currently individually review AGAR plates, of which up to 95% return negative results. The APAS® Independence rapidly and automatically reviews and sorts plates into neat stacks of positives, negatives and plates to be reviewed; at a rate of 200 plates per hour.

Feedback on this St Vincent’s operation is expected during Q4 this calendar year. The APAS® Independence will undergo further commercial evaluations over the next 18 months in additional microbiology centers of excellence globally to establish a network of reference laboratories.

Successful deployment at the reference laboratories is a precursor to larger scale commercial roll out of the APAS® Independence.


more about LBT innovations


 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events